Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.57 USD | +0.19% | -0.75% | +22.06% |
Financials (USD)
Sales 2024 * | 378M | Sales 2025 * | 446M | Capitalization | 2.17B |
---|---|---|---|---|---|
Net income 2024 * | -57M | Net income 2025 * | 34M | EV / Sales 2024 * | 5.15 x |
Net cash position 2024 * | 219M | Net cash position 2025 * | 338M | EV / Sales 2025 * | 4.1 x |
P/E ratio 2024 * |
-35.4
x | P/E ratio 2025 * |
75.2
x | Employees | 1,008 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.14% |
Latest transcript on Cellebrite DI Ltd.
1 day | +0.19% | ||
1 week | -0.75% | ||
Current month | -0.75% | ||
1 month | -6.21% | ||
3 months | -9.43% | ||
6 months | +25.98% | ||
Current year | +22.06% |
Managers | Title | Age | Since |
---|---|---|---|
Yossi Carmil
CEO | Chief Executive Officer | 57 | 03-12-31 |
Dana Gerner
DFI | Director of Finance/CFO | 56 | 14-05-06 |
Ayala Shapira
CMP | Compliance Officer | 53 | 22-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Clammer
BRD | Director/Board Member | 53 | 21-08-29 |
Thomas Hogan
CHM | Chairman | 64 | 23-08-07 |
Dafna Gruber
BRD | Director/Board Member | 58 | 21-08-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +5.53% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 10.57 | +0.19% | 444,082 |
24-06-06 | 10.55 | +0.29% | 795,296 |
24-06-05 | 10.52 | +1.06% | 710,222 |
24-06-04 | 10.41 | -0.29% | 612,199 |
24-06-03 | 10.44 | -1.97% | 690,798 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.06% | 2.17B | |
+12.71% | 3,155B | |
+10.98% | 87.92B | |
+8.10% | 81.08B | |
-16.04% | 53.91B | |
+35.76% | 52.98B | |
+30.86% | 47.54B | |
-31.32% | 42.55B | |
+78.94% | 41.35B | |
+2.37% | 28.39B |
- Stock Market
- Equities
- CLBT Stock